Phosphatase and tensin homologue protein loss is found in 35% of triple‐negative; 11% of HR+, HER2‐negative; 5% of HR+, HER2‐positive; and 6% of HR–, HER2‐positive breast cancers.21 Here, ERBB2 is linked to breast carcinoma.